1 Market Overview

1.1 Product Overview and Scope of Personalized Medicines In Oncology

1.2 Classification of Personalized Medicines In Oncology by Service

1.2.1 Overview: Global Personalized Medicines In Oncology Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Personalized Medicines In Oncology Revenue Market Share by Type in 2020

1.2.3 Molecular Oncopathology

1.2.4 Genome Diagnostics

1.2.5 Radiation Therapy

1.2.6 Oncology Testing

1.2.7 Chemotherapy

1.2.8 Others

1.3 Global Personalized Medicines In Oncology Market by End Users

1.3.1 Overview: Global Personalized Medicines In Oncology Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Research Centers

1.3.3 Governmental Institutions

1.3.4 Hospitals

1.3.5 Clinical Centers

1.3.6 Others

1.4 Global Personalized Medicines In Oncology Market Size & Forecast

1.5 Global Personalized Medicines In Oncology Market Size and Forecast by Region

1.5.1 Global Personalized Medicines In Oncology Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Personalized Medicines In Oncology Market Size by Region, (2016-2021)

1.5.3 North America Personalized Medicines In Oncology Market Size and Prospect (2016-2026)

1.5.4 Europe Personalized Medicines In Oncology Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Personalized Medicines In Oncology Market Size and Prospect (2016-2026)

1.5.6 South America Personalized Medicines In Oncology Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Personalized Medicines In Oncology Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Personalized Medicines In Oncology Market Drivers

1.6.2 Personalized Medicines In Oncology Market Restraints

1.6.3 Personalized Medicines In Oncology Trends Analysis

2 Company Profiles

2.1 Biotheranostics

2.1.1 Biotheranostics Details

2.1.2 Biotheranostics Major Business

2.1.3 Biotheranostics Personalized Medicines In Oncology Product and Solutions

2.1.4 Biotheranostics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Biotheranostics Recent Developments and Future Plans

2.2 Illumina

2.2.1 Illumina Details

2.2.2 Illumina Major Business

2.2.3 Illumina Personalized Medicines In Oncology Product and Solutions

2.2.4 Illumina Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Illumina Recent Developments and Future Plans

2.3 DNA Link

2.3.1 DNA Link Details

2.3.2 DNA Link Major Business

2.3.3 DNA Link Personalized Medicines In Oncology Product and Solutions

2.3.4 DNA Link Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 DNA Link Recent Developments and Future Plans

2.4 Genomic Health, Inc.(Exact Sciences)

2.4.1 Genomic Health, Inc.(Exact Sciences) Details

2.4.2 Genomic Health, Inc.(Exact Sciences) Major Business

2.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product and Solutions

2.4.4 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Genomic Health, Inc.(Exact Sciences) Recent Developments and Future Plans

2.5 Cypher Genomics(Human Longevity, Inc.)

2.5.1 Cypher Genomics(Human Longevity, Inc.) Details

2.5.2 Cypher Genomics(Human Longevity, Inc.) Major Business

2.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product and Solutions

2.5.4 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Cypher Genomics(Human Longevity, Inc.) Recent Developments and Future Plans

2.6 Life Technologies Corporation(Thermo Fisher Scientific)

2.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Details

2.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Major Business

2.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product and Solutions

2.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Recent Developments and Future Plans

2.7 Fulgent Genetics

2.7.1 Fulgent Genetics Details

2.7.2 Fulgent Genetics Major Business

2.7.3 Fulgent Genetics Personalized Medicines In Oncology Product and Solutions

2.7.4 Fulgent Genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Fulgent Genetics Recent Developments and Future Plans

2.8 Caris Life Sciences

2.8.1 Caris Life Sciences Details

2.8.2 Caris Life Sciences Major Business

2.8.3 Caris Life Sciences Personalized Medicines In Oncology Product and Solutions

2.8.4 Caris Life Sciences Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Caris Life Sciences Recent Developments and Future Plans

2.9 Ariana Pharma

2.9.1 Ariana Pharma Details

2.9.2 Ariana Pharma Major Business

2.9.3 Ariana Pharma Personalized Medicines In Oncology Product and Solutions

2.9.4 Ariana Pharma Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Ariana Pharma Recent Developments and Future Plans

2.10 Abbott Laboratories

2.10.1 Abbott Laboratories Details

2.10.2 Abbott Laboratories Major Business

2.10.3 Abbott Laboratories Personalized Medicines In Oncology Product and Solutions

2.10.4 Abbott Laboratories Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Abbott Laboratories Recent Developments and Future Plans

2.11 deCODE genetics

2.11.1 deCODE genetics Details

2.11.2 deCODE genetics Major Business

2.11.3 deCODE genetics Personalized Medicines In Oncology Product and Solutions

2.11.4 deCODE genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 deCODE genetics Recent Developments and Future Plans

2.12 Exagen Inc

2.12.1 Exagen Inc Details

2.12.2 Exagen Inc Major Business

2.12.3 Exagen Inc Personalized Medicines In Oncology Product and Solutions

2.12.4 Exagen Inc Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Exagen Inc Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Personalized Medicines In Oncology Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 5 Personalized Medicines In Oncology Players Market Share

3.2.2 Top 10 Personalized Medicines In Oncology Players Market Share

3.2.3 Market Competition Trend

3.3 Personalized Medicines In Oncology Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Personalized Medicines In Oncology Revenue and Market Share by Type (2016-2021)

4.2 Global Personalized Medicines In Oncology Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Personalized Medicines In Oncology Revenue Market Share by Application (2016-2021)

5.2 Personalized Medicines In Oncology Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Personalized Medicines In Oncology Revenue by Type (2016-2026)

6.2 North America Personalized Medicines In Oncology Revenue by Application (2016-2026)

6.3 North America Personalized Medicines In Oncology Market Size by Country

6.3.1 North America Personalized Medicines In Oncology Revenue by Country (2016-2026)

6.3.2 United States Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

6.3.3 Canada Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

6.3.4 Mexico Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Personalized Medicines In Oncology Revenue by Type (2016-2026)

7.2 Europe Personalized Medicines In Oncology Revenue by Application (2016-2026)

7.3 Europe Personalized Medicines In Oncology Market Size by Country

7.3.1 Europe Personalized Medicines In Oncology Revenue by Country (2016-2026)

7.3.2 Germany Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

7.3.3 France Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

7.3.5 Russia Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

7.3.6 Italy Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Personalized Medicines In Oncology Revenue by Type (2016-2026)

8.2 Asia-Pacific Personalized Medicines In Oncology Revenue by Application (2016-2026)

8.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Region

8.3.1 Asia-Pacific Personalized Medicines In Oncology Revenue by Region (2016-2026)

8.3.2 China Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

8.3.3 Japan Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

8.3.4 South Korea Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

8.3.5 India Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

8.3.7 Australia Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Personalized Medicines In Oncology Revenue by Type (2016-2026)

9.2 South America Personalized Medicines In Oncology Revenue by Application (2016-2026)

9.3 South America Personalized Medicines In Oncology Market Size by Country

9.3.1 South America Personalized Medicines In Oncology Revenue by Country (2016-2026)

9.3.2 Brazil Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

9.3.3 Argentina Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Personalized Medicines In Oncology Revenue by Type (2016-2026)

10.2 Middle East & Africa Personalized Medicines In Oncology Revenue by Application (2016-2026)

10.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Country

10.3.1 Middle East & Africa Personalized Medicines In Oncology Revenue by Country (2016-2026)

10.3.2 Turkey Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

10.3.4 UAE Personalized Medicines In Oncology Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Personalized Medicines In Oncology Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Personalized Medicines In Oncology Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Personalized Medicines In Oncology Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Personalized Medicines In Oncology Revenue (USD Million) by Region (2016-2021)

Table 5. Global Personalized Medicines In Oncology Revenue Market Share by Region (2021-2026)

Table 6. Biotheranostics Corporate Information, Head Office, and Major Competitors

Table 7. Biotheranostics Major Business

Table 8. Biotheranostics Personalized Medicines In Oncology Product and Solutions

Table 9. Biotheranostics Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Illumina Corporate Information, Head Office, and Major Competitors

Table 11. Illumina Major Business

Table 12. Illumina Personalized Medicines In Oncology Product and Solutions

Table 13. Illumina Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. DNA Link Corporate Information, Head Office, and Major Competitors

Table 15. DNA Link Major Business

Table 16. DNA Link Personalized Medicines In Oncology Product and Solutions

Table 17. DNA Link Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Genomic Health, Inc.(Exact Sciences) Corporate Information, Head Office, and Major Competitors

Table 19. Genomic Health, Inc.(Exact Sciences) Major Business

Table 20. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product and Solutions

Table 21. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Cypher Genomics(Human Longevity, Inc.) Corporate Information, Head Office, and Major Competitors

Table 23. Cypher Genomics(Human Longevity, Inc.) Major Business

Table 24. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product and Solutions

Table 25. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Life Technologies Corporation(Thermo Fisher Scientific) Corporate Information, Head Office, and Major Competitors

Table 27. Life Technologies Corporation(Thermo Fisher Scientific) Major Business

Table 28. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product and Solutions

Table 29. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Fulgent Genetics Corporate Information, Head Office, and Major Competitors

Table 31. Fulgent Genetics Major Business

Table 32. Fulgent Genetics Personalized Medicines In Oncology Product and Solutions

Table 33. Fulgent Genetics Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Caris Life Sciences Corporate Information, Head Office, and Major Competitors

Table 35. Caris Life Sciences Major Business

Table 36. Caris Life Sciences Personalized Medicines In Oncology Product and Solutions

Table 37. Caris Life Sciences Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Ariana Pharma Corporate Information, Head Office, and Major Competitors

Table 39. Ariana Pharma Major Business

Table 40. Ariana Pharma Personalized Medicines In Oncology Product and Solutions

Table 41. Ariana Pharma Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 43. Abbott Laboratories Major Business

Table 44. Abbott Laboratories Personalized Medicines In Oncology Product and Solutions

Table 45. Abbott Laboratories Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. deCODE genetics Corporate Information, Head Office, and Major Competitors

Table 47. deCODE genetics Major Business

Table 48. deCODE genetics Personalized Medicines In Oncology Product and Solutions

Table 49. deCODE genetics Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Exagen Inc Corporate Information, Head Office, and Major Competitors

Table 51. Exagen Inc Major Business

Table 52. Exagen Inc Personalized Medicines In Oncology Product and Solutions

Table 53. Exagen Inc Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Global Personalized Medicines In Oncology Revenue (USD Million) by Players (2019-2021)

Table 55. Global Personalized Medicines In Oncology Revenue Share by Players (2019-2021)

Table 56. Breakdown of Personalized Medicines In Oncology by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Personalized Medicines In Oncology Players Head Office, Products and Services Provided

Table 58. Personalized Medicines In Oncology Mergers & Acquisitions in the Past Five Years

Table 59. Personalized Medicines In Oncology New Entrants and Expansion Plans

Table 60. Global Personalized Medicines In Oncology Revenue (USD Million) by Type (2016-2021)

Table 61. Global Personalized Medicines In Oncology Revenue Share by Type (2016-2021)

Table 62. Global Personalized Medicines In Oncology Revenue Forecast by Type (2021-2026)

Table 63. Global Personalized Medicines In Oncology Revenue by Application (2016-2021)

Table 64. Global Personalized Medicines In Oncology Revenue Forecast by Application (2021-2026)

Table 65. North America Personalized Medicines In Oncology Revenue by Type (2016-2021) & (USD Million)

Table 66. North America Personalized Medicines In Oncology Revenue by Type (2021-2026) & (USD Million)

Table 67. North America Personalized Medicines In Oncology Revenue by Application (2016-2021) & (USD Million)

Table 68. North America Personalized Medicines In Oncology Revenue by Application (2021-2026) & (USD Million)

Table 69. North America Personalized Medicines In Oncology Revenue by Country (2016-2021) & (USD Million)

Table 70. North America Personalized Medicines In Oncology Revenue by Country (2021-2026) & (USD Million)

Table 71. Europe Personalized Medicines In Oncology Revenue by Type (2016-2021) & (USD Million)

Table 72. Europe Personalized Medicines In Oncology Revenue by Type (2021-2026) & (USD Million)

Table 73. Europe Personalized Medicines In Oncology Revenue by Application (2016-2021) & (USD Million)

Table 74. Europe Personalized Medicines In Oncology Revenue by Application (2021-2026) & (USD Million)

Table 75. Europe Personalized Medicines In Oncology Revenue by Country (2016-2021) & (USD Million)

Table 76. Europe Personalized Medicines In Oncology Revenue by Country (2021-2026) & (USD Million)

Table 77. Asia-Pacific Personalized Medicines In Oncology Revenue by Type (2016-2021) & (USD Million)

Table 78. Asia-Pacific Personalized Medicines In Oncology Revenue by Type (2021-2026) & (USD Million)

Table 79. Asia-Pacific Personalized Medicines In Oncology Revenue by Application (2016-2021) & (USD Million)

Table 80. Asia-Pacific Personalized Medicines In Oncology Revenue by Application (2021-2026) & (USD Million)

Table 81. Asia-Pacific Personalized Medicines In Oncology Revenue by Region (2016-2021) & (USD Million)

Table 82. Asia-Pacific Personalized Medicines In Oncology Revenue by Region (2021-2026) & (USD Million)

Table 83. South America Personalized Medicines In Oncology Revenue by Type (2016-2021) & (USD Million)

Table 84. South America Personalized Medicines In Oncology Revenue by Type (2021-2026) & (USD Million)

Table 85. South America Personalized Medicines In Oncology Revenue by Application (2016-2021) & (USD Million)

Table 86. South America Personalized Medicines In Oncology Revenue by Application (2021-2026) & (USD Million)

Table 87. South America Personalized Medicines In Oncology Revenue by Country (2016-2021) & (USD Million)

Table 88. South America Personalized Medicines In Oncology Revenue by Country (2021-2026) & (USD Million)

Table 89. Middle East & Africa Personalized Medicines In Oncology Revenue by Type (2016-2021) & (USD Million)

Table 90. Middle East & Africa Personalized Medicines In Oncology Revenue by Type (2021-2026) & (USD Million)

Table 91. Middle East & Africa Personalized Medicines In Oncology Revenue by Application (2016-2021) & (USD Million)

Table 92. Middle East & Africa Personalized Medicines In Oncology Revenue by Application (2021-2026) & (USD Million)

Table 93. Middle East & Africa Personalized Medicines In Oncology Revenue by Country (2016-2021) & (USD Million)

Table 94. Middle East & Africa Personalized Medicines In Oncology Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Personalized Medicines In Oncology Picture

Figure 2. Global Personalized Medicines In Oncology Revenue Market Share by Service in 2020

Figure 3. Molecular Oncopathology

Figure 4. Genome Diagnostics

Figure 5. Radiation Therapy

Figure 6. Oncology Testing

Figure 7. Chemotherapy

Figure 8. Others

Figure 9. Personalized Medicines In Oncology Revenue Market Share by End Users in 2020

Figure 10. Research Centers Picture

Figure 11. Governmental Institutions Picture

Figure 12. Hospitals Picture

Figure 13. Clinical Centers Picture

Figure 14. Others Picture

Figure 15. Global Personalized Medicines In Oncology Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 16. Global Personalized Medicines In Oncology Revenue and Forecast (2016-2026) & (USD Million)

Figure 17. Global Personalized Medicines In Oncology Revenue Market Share by Region (2016-2026)

Figure 18. Global Personalized Medicines In Oncology Revenue Market Share by Region in 2020

Figure 19. North America Personalized Medicines In Oncology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Europe Personalized Medicines In Oncology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Asia-Pacific Personalized Medicines In Oncology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. South America Personalized Medicines In Oncology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Personalized Medicines In Oncology Market Drivers

Figure 24. Personalized Medicines In Oncology Market Restraints

Figure 25. Personalized Medicines In Oncology Market Trends

Figure 26. Biotheranostics Recent Developments and Future Plans

Figure 27. Illumina Recent Developments and Future Plans

Figure 28. DNA Link Recent Developments and Future Plans

Figure 29. Genomic Health, Inc.(Exact Sciences) Recent Developments and Future Plans

Figure 30. Cypher Genomics(Human Longevity, Inc.) Recent Developments and Future Plans

Figure 31. Life Technologies Corporation(Thermo Fisher Scientific) Recent Developments and Future Plans

Figure 32. Fulgent Genetics Recent Developments and Future Plans

Figure 33. Caris Life Sciences Recent Developments and Future Plans

Figure 34. Ariana Pharma Recent Developments and Future Plans

Figure 35. Abbott Laboratories Recent Developments and Future Plans

Figure 36. deCODE genetics Recent Developments and Future Plans

Figure 37. Exagen Inc Recent Developments and Future Plans

Figure 39. Global Personalized Medicines In Oncology Revenue Share by Players in 2020

Figure 40. Personalized Medicines In Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 41. Global Top 3 Players Personalized Medicines In Oncology Revenue Market Share in 2020

Figure 42. Global Top 10 Players Personalized Medicines In Oncology Revenue Market Share in 2020

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 44. Global Personalized Medicines In Oncology Revenue Share by Type in 2020

Figure 45. Global Personalized Medicines In Oncology Market Share Forecast by Type (2021-2026)

Figure 46. Global Personalized Medicines In Oncology Revenue Share by Application in 2020

Figure 47. Global Personalized Medicines In Oncology Market Share Forecast by Application (2021-2026)

Figure 48. North America Personalized Medicines In Oncology Sales Market Share by Type (2016-2026)

Figure 49. North America Personalized Medicines In Oncology Sales Market Share by Application (2016-2026)

Figure 50. North America Personalized Medicines In Oncology Revenue Market Share by Country (2016-2026)

Figure 51. United States Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Canada Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Mexico Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Europe Personalized Medicines In Oncology Sales Market Share by Type (2016-2026)

Figure 55. Europe Personalized Medicines In Oncology Sales Market Share by Application (2016-2026)

Figure 56. Europe Personalized Medicines In Oncology Revenue Market Share by Country (2016-2026)

Figure 57. Germany Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. France Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. United Kingdom Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Russia Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Italy Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Asia-Pacific Personalized Medicines In Oncology Sales Market Share by Type (2016-2026)

Figure 63. Asia-Pacific Personalized Medicines In Oncology Sales Market Share by Application (2016-2026)

Figure 64. Asia-Pacific Personalized Medicines In Oncology Revenue Market Share by Region (2016-2026)

Figure 65. China Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Japan Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South Korea Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. India Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Southeast Asia Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Australia Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South America Personalized Medicines In Oncology Sales Market Share by Type (2016-2026)

Figure 72. South America Personalized Medicines In Oncology Sales Market Share by Application (2016-2026)

Figure 73. South America Personalized Medicines In Oncology Revenue Market Share by Country (2016-2026)

Figure 74. Brazil Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Argentina Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Middle East and Africa Personalized Medicines In Oncology Sales Market Share by Type (2016-2026)

Figure 77. Middle East and Africa Personalized Medicines In Oncology Sales Market Share by Application (2016-2026)

Figure 78. Middle East and Africa Personalized Medicines In Oncology Revenue Market Share by Country (2016-2026)

Figure 79. Turkey Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Saudi Arabia Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. UAE Personalized Medicines In Oncology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source